ÂÜÀòÂÒÂ×

Jenny Yip is a highly experienced professional in the healthcare and investment sectors, currently serving as Managing Partner at Adjuvant Capital since February 2019. Yip holds multiple leadership roles, including Director at ReSurge International and Antiva Biosciences, Inc., and Board Observer at Excision BioTherapeutics. Additionally, Yip is an Advisory Board Member for Harvard School of Public Health Magazine and has served as a Director at ChromaCode, Inc. and 54gene, among other positions. With a background in venture capital, Yip was also a member of the LPAC and Social Impact Committees at Reach Capital and Owl Ventures, LP from 2015 to 2019. Yip earned an AB in History of Science from Harvard University, which was completed in 2003.